4Oon CJ,Chen WN,Lim N,et al.Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the ""a"" epitope of the surface antigen are sensitive to ganciclovir[J].Antiviral Res ,1999,41:113
5Tokimasa S,Hara J,Osugi Y,et al.Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation[J].Bone Marrow Transplant,2002,29(7) :595
6Henkin CC,Griener JC,Ten Eick AP.Stability of valganciclovir in extemporaneously compounded liquid formulations[J].Am J Health Syst Pharm,2003,60: 687
7Emery V C,Hassan- Walker AF.Focus on new drugs in development against human cytomegalovirus[J].Drugs,2002,62(13): 1853
8Pat weiskittel.Valganciclovir hydrochloride: a new antiviral agent[J].JNephrolNurs,2003,30(1):93
9Bozkaya H,Yurdaydin C,Bozdayi AM,et al.Oral ganciclovir for treatment of lamivudine-resistant hepatitis B Virus infection: a pilot study[J].Clin Infect Dis,2002,35: 960
10Hadziyannis SJ,Manesis EK,Papakonstantinou A.Oral ganciclovir treatment in chronic hepatitis B virus infection: a pilot study[J].J Hepatol,1999,31:210
